(Reuters) – Qiagen is to collaborate with Sophia Genetics on its next-generation sequencing (NGS) kits, the US-German pharmaceutical company said on Wednesday.
The alliance, part of Qiagen’s Qiqseq platform partnership program, aims to increase the compatibility of its NGS kits with third-party digital data-sharing and analytics companies.
“The partnership with Sophia Genetics is planned to be expanded to other areas of analysis,” it added.
(Reporting by Tristan Chabba in Gdansk; Editing by Miranda Murray)
